Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

Mahtta, Dhruv, Ramsey, David J., Lee, Michelle T., Chen, Liang, Al Rifai, Mahmoud, Akeroyd, Julia M., Vaughan, Elizabeth M., Matheny, Michael E. +7 more·2022·Diabetes Care

DOI 10.2337/dc21-1815

Cited by (137)

Items 101–137 of 137

Glucose-Lowering Drugs with Proven Cardiovascular Benefit Following Acute Coronary Syndrome in Patients with Type 2 Diabetes: Treatment Gaps and Outcomes
Ibrahim Naoum, Walid I. Saliba, Ofra Barnett‐Griness, Amir Aker, Barak Zafrir · 2024 · Journal of Clinical Medicine
Impact of American Diabetes Association 2022 Guidelines on Prescribing Rates of Sodium-Glucose Cotransporter-2 Inhibitors in Ambulatory Care Organization Patients With Type 2 Diabetes
Alexis R. Bogannam, Ewan D McNicol, Kevin DeLeonardo, Ashwini Ranade, Kathy Zaiken · 2024 · Journal of Pharmacy Practice
Brave New World: Improving Obesity and Preventing Cardiovascular Disease
James Henry O’Keefe, Evan L. O’Keefe, Michael E. Nassif, Carl J. Lavie · 2023 · Mayo Clinic Proceedings
Corrigendum to : Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV
Bakani Butale, Ian John Woolley, Kathryn Cisera, Tony M. Korman, Georgia Soldatos · 2022 · Sexual Health
Racial and ethnic disparities in early uptake of GLP-1 receptor agonists in patients with and without MASLD
Sarpong Boateng, Prince Addo. Ameyaw, Yussif Issaka, Yazan A. Al‐Ajlouni, Basile M. Njei · 2025 · Research Square
Typ-2-Diabetes: Utilisationsraten von SGLT2-Inhibitoren und GLP-1-Agonisten
Susanne Krome · 2022 · Diabetologie und Stoffwechsel
A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart Disease Among Patients with Diabetes and/or Obesity
Nkiru Osude, Neha Jadeja Pagidipati · 2023 · Medical Clinics of North America
Noninsulin antidiabetic prescription patterns in Colombia: a cross-sectional study
Jorge Enrique Machado‐Alba, Andrés Gaviria‐Mendoza, Manuel Enrique Machado‐Duque, Luis Fernando Valladales‐Restrepo, Andrés Alvarado-Segovia · 2024 · Therapeutic Advances in Endocrinology and Metabolism
Global Multidisciplinary Cardiometabolic Care Delivery
Denise K. Busman, Miguel Javier Schiavone, Nicolas Federico Renna, Shone O Almeida, Erica Pivato, Jessica Mollmann, Katie Willerick, Ginger K. Biesbrock · 2024 · JACC Case Reports
Is This the Real Life? Real-World Evidence of Empagliflozin in Health Care Resource Utilization and Cost
Josephine Harrington, Yu Mi Kang, Darren K. McGuire · 2024 · Diabetes Care
Impact of Prescribing Patterns Before and After Short-Term, Pharmacist-Led Type 2 Diabetes Service in an Endocrinology Clinic
Rita Parsiani, Francine Mendoza, Leah M. Wilson, Farahnaz Joarder, Roula Zahr, Andrew Ahmann, Siting Chen, Haemin Lee · 2024 · Diabetes Spectrum
Increasing SGLT-2 inhibitor prescribing through an integrated case-finding algorithm-guided interdisciplinary intervention
Cindy Leslie A. Roberson, Abby F. Hoffman, Pamela Cohen, Victoria Lee Jackson, Susan E. Spratt · 2024 · Journal of the American Pharmacists Association
Association of Endocrinologists on Clinical Care Team With Sodium–Glucose Cotransporter 2 Inhibitor Prescription for People With Type 2 Diabetes After Coronary Artery Bypass Grafting: A Two-Center Study
Yangtian Yi, Nicolas Kumar, Matthew Raymond Smith, Ariel Mueller, Timothy T. Houle, Arminder Singh Jassar, Lauren J. Cornella, Robert B. Schonberger, Amit Bardia · 2025 · Clinical Diabetes
The Effectiveness of an Electronic Decision Support Algorithm to Optimize Recommendations of SGLT2i and GLP-1RA in Patients with Type 2 Diabetes upon Discharge from Internal Medicine Wards
Irit Ayalon‐Dangur, Emily Jaffe, Alon Grossman, Hagit Hendel, Yossi Oved, Amir Shaked, Ilan Shimon, Bar Basharim, Mohamad Abo Molhem, Rotem McNeil et al. · 2025 · Journal of Clinical Medicine
Bridging the Gap: Pragmatic Strategies to Overcome Barriers in the Implementation of Cardiometabolic Care
Lauren Eyadiel, Taher Modarressi · 2025 · Journal of Cardiac Failure - Intersections
In Search of Commonality: Physiological and Therapeutic Potentials of Sodium-Glucose Transport Protein 2 Inhibitors in Cardiovascular and Chronic Kidney Diseases
Khalid Sawalha, Lana Alamat, Aakash Rana, Landon Bruich, Angel Lopez Candales · 2025 · Cureus
Prescribing trends of cardioprotective medications among patients with diabetes and ASCVD in primary care setting in Qatar
Myriam Jihad Jaam, Ahmed Awaisu, Daoud Al‐Badriyeh, Amani Zidan, Rana Abu Samaha, Basant Elkattan, Zanfina Ademi, Mohamed Ghaith Al‐Kuwari, Abdulrouf Pallivalapila, Jazeel Abdulmajeed et al. · 2025 · Journal of Pharmaceutical Policy and Practice
Additional file 1 of Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure
Tye, Sok Cin, Niels Jongs, Steven G. Coca, Johan Sundström, Arnott, Clare, Neal, Bruce, Vlado Perkovic, Kenneth W. Mahaffey, Vart, Priya, Heerspink, Hiddo. J. L. · 2022 · Figshare
Approach to the patient with type 2 diabetes treated with SGLT-2 inhibitor: art of effective and safe prescription
Aidar R. Gosmanov · 2025 · The Journal of Clinical Endocrinology & Metabolism
Impact of ethnicity and antihyperglycemic medications on dementia incidence in older adults with type 2 diabetes
Elena Chertok Shacham, Sireen Sharif, Muhammad Kadah, S. Ayalon · 2026 · Endocrine Connections
Comparative Evaluation of Rule-Based and Transformer-Based Text-Mining Methods for Detecting SGLT2 Inhibitor Mentions in Unstructured Clinical Free Text
Attila Csaba Nagy · 2026 · Technologies
SGLT‐2 Inhibitors Use in Hospitalized Patients in France: A Cross‐Sectional Study
Maxime Demourgues, Julien Bezin, Romain Griffier, Antoine Pariente, Pernelle Noïze, Sibylle de Germay · 2026 · Fundamental and Clinical Pharmacology
The Quality Chasm and the Need for Implementation Science to Reduce Cardiovascular Disease Risk in Type 2 Diabetes
Neha J. Pagidipati · 2026 · Elsevier eBooks
Evaluation of clinical decision support to improve guideline directed medical therapy in patients with type 2 diabetes
Kelsey Ernst, Christopher Zimmerman, Devraj Sukul, Elizabeth (Liza) Renner, Lillian Wang, Amy N. Thompson, Sarah K. Adie, Heidi L. Diez · 2026 · Journal of the American Pharmacists Association
Type 2 Diabetes Severity Modifies Long-Term Health Expenditures After Metabolic Bariatric Surgery
Caroline E. Sloan, Lindsay Zepel, Valerie A. Smith, David E Arterburn, Aileen S. Baecker, Aniket A. Kawatkar, Julietta Chang, Amy G. Clark, Matthew L. Maciejewski · 2026 · Obesity Surgery
Trends in Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon‑Like Peptide‑1 Receptor Agonist Prescription Rates Among Patients With Type 2 Diabetes: An Epic Cosmos Real-World Data Analysis, 2014-2024
Donglan Stacy Zhang, ANAND RAJAN, Shahidul Islam, David M. Charytan, Alan Jacobson, Davene R. Wright, Jordan Weiss, Jasmin Divers · 2026 · AACE Endocrinology and Diabetes
Implementation of a Pharmacist-Led Service to Expand SGLT2 Inhibitor Use Beyond Diabetes in the Primary Care Setting
Stacey Cutrell, Kiara Patino, R. Oluwafunmito Babalola, Michael Murchie, John D. Bucheit · 2026 · The Science of Diabetes Self-Management and Care
The Diabetes Staging System (DSS): A Pilot Study Assessing Feasibility, Provider Engagement and Implementation Challenges of a Novel Staging System for Type 2 Diabetes
Moahad Saeed Dar, Junhong Zhang, ANNA ASHLINE, Swetha Kota, Sandra Woolson, Nadya T. Majette, Hayden Barry Bosworth · 2026 · Diabetes Metabolic Syndrome and Obesity
Cardioprotective therapy in type 2 diabetes guided by a proteomic risk model: A randomized trial
Rosalynn D. Gill, Meredith A. Carpenter, Amy Holstein, Ariadne Reyes Garcia, Ayman Alkholder, Aanchal Gupta, Vatsala Singh, Arshed Ali Quyyumi, Neda Rasouli, Ian J. Neeland et al. · 2026 · American Journal of Preventive Cardiology
Racial and ethnic disparities in GLP-1 prescriptions among veterans with obesity across direct and community care settings
Rebekah I. Stein, Jessica Phelan, Austin B. Frakt, Steven D. Pizer, Melissa M. Garrido, Endel John Orav, José F. Figueroa, Thomas C. Tsai · 2026 · Health Affairs Scholar
Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center
Eleonora Avenatti, Archana Sadhu, Rakesh Gullapelli, Aditi Rao, Chetan Pavuluri, Khurram Nasir, Sangeeta R. Kashyap · 2026 · American Journal of Preventive Cardiology
Challenges implementing treatment guidelines in electronic health records: the American Diabetes Association Standards of Care as a case example
Irene Demarie, Michael E. Bowen, Shubham Agarwal, Christine Mai, KELSEA MARBLE, Jonathan Pak, Daniel F. Heitjan, Zichang Xiang, Christoph Ulrich Lehmann, Ildiko Lingvay et al. · 2026 · JAMIA Open
Adherence to Antihypertensive Medications in Chronic Kidney Disease
Aikaterini Damianaki, Michel Burnier · 2026 · Updates in hypertension and cardiovascular protection
Knowledge, attitudes, and practices of Saudi physicians toward the use of SGLT-2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus: a nationwide cross-sectional study
Marwan A. Alrasheed, Bader M. Alhadhrami, Abdulaziz Abdullah Alqarni, Nawaf Mohammed Alghamdi, Omar A. Alfurayh, Omar A. Almohammed · 2026 · Frontiers in Endocrinology
Remote Endocrinology Support for Primary Care Clinicians Managing Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
Abdulelah F Alshehri, Dana Naif Al-Dahmashi, Farah Safaq Al-Dahmashi, Reem Taif Al-Dahmashi, Dana Atallah Alanazi, Yasmeen Atallah Alenazi, Remas Khalid Alanazi, Shumukh Mohammed Al-Anazi, Asayil Ayed Al-Anazi, Shahad Hamoud Al-Anazi et al. · 2026 · Cureus
Cardiovascular risk profile and treatment patterns in patients with type 2 diabetes in specialized cardiology outpatient care in Colombia
Lucia Suárez Maestre, Ingrith Paola Hoyos Montaño, Zenen David Rua Osorio, Carlos Renowitzky Zabarain, Alex Dominguez Vargas, Henry Joseth González-Torres · 2026 · Medicine
Prescribing SGLTis and GLP-1 RAs for Patients With Type 2 Diabetes, Guideline Updates, and Longitudinal Knowledge Assessment Scores
Bradley Michael Gray, Jonathan L. Vandergrift, Bruce E. Landon, Rozalina McCoy · 2026 · JAMA Network Open